1st Oct 2013 16:17
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc.
On 30 September 2013, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £15.74 per Ordinary Share, and notional ADSs at a price of $50.53 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 July 2013 to 30 September 2013:
Non Executive Director | Ordinary Shares | American Depositary Shares (ADSs) |
Sir Christopher Gent | 2,700.127 | |
Professor Sir Roy Anderson | 456.639 | |
Dr Stephanie Burns |
| 456.882 |
Stacey Cartwright | 337.516 | |
Lynn Elsenhans | 822.388 | |
Judy Lewent | 387.357 | |
Sir Deryck Maughan | 1,152.137 | |
Dr Daniel Podolsky | 863.509 | |
Tom de Swaan | 416.931 | |
Jing Ulrich | 228.441 | |
Hans Wijers | 337.516 | |
Sir Robert Wilson | 337.516 | |
The Company and the Non-Executive Directors were informed of these allocations on 1 October 2013.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
S M Bicknell
Company Secretary
1 October 2013
Related Shares:
Glaxosmithkline